Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse.

Molecular & cellular proteomics : MCP - 1 Aug 2020

Rijensky Nataly Mancette, Blondheim Shraga Netta R, Barnea Eilon, Peled Nir, Rosenbaum Eli, Popovtzer Aron, Stemmer Solomon M, Livoff Alejandro, Shlapobersky Mark, Moskovits Neta, Perry Dafna, Rubin Eitan, Haviv Itzhak, Admon Arie

Abstract excerpt

Personalized cancer immunotherapy targeting patient-specific cancer/testis antigens (CTA) and neoantigens may benefit from large-scale tumor human leukocyte antigen (HLA) peptidome (immunopeptidome) analysis, which aims to accurately identify antigens presented by tumor cells. Although significant efforts have been invested in analyzing the HLA peptidomes of fresh tumors, it is often impossible to obtain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cluster Analysis

Share to HLA Antigens

Share to Peptides

Share to Proteome

Share to Xenograft Model Antitumor Assays

Source

Open in PubMed Open full text

Identifiers

PMID: 32451349
DOI: 10.1074/mcp.RA119.001876
PMCID: PMC8015002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse.PMID 32451349Read ↗

PCI-DB: A novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy developmentSemantic proximity Read ↗

Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinomaSemantic proximity Read ↗

Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated GenesSemantic proximity Read ↗

Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.Semantic proximity Read ↗

Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltrationSemantic proximity Read ↗

Deciphering the tumor-specific immunopeptidome in vivo with genetically engineered mouse modelsSemantic proximity Read ↗

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.Semantic proximity Read ↗

Deciphering the tumor-specific immunopeptidome <i>in vivo</i> with genetically engineered mouse modelsSemantic proximity Read ↗

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationSemantic proximity Read ↗

Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigensSemantic proximity Read ↗

Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discoverySemantic proximity Read ↗

Human Tumor Antigens Yesterday, Today, and TomorrowSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.